Amboy Street Ventures is the world's first venture capital fund focused on Women's Health and Sexual Wellbeing for all genders. The firm invests in the Seed and Series A rounds of startups across maternal health, menopause, fertility, hormonal health, abortion access, LGBTQ+ health, and sexual health and pleasure.
42% of their portfolio is in Healthcare. Their most common stage is series-a (67% of deals). Average disclosed round size is $9.1M (across 10 rounds with reported amounts).
Portfolio
12
Fund Size
$20M
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nest Health | Series A | $12.5M | Oct 2025 |
 Granata Bio | Series A | $15M | Jan 2025 |
 Millie | Series A | $12M | Jan 2025 |
 Evvy | Series A | — | Sep 2023 |
 HerMD | Series A | $18M | Jul 2023 |
 DAME | Series A | — | Sep 2022 |
 Aunt Flow | Series A | $8.5M | Apr 2022 |
| DDame Products | Series A | $7M | — |
| TTestmate Health | Seed | $6M | — |
 Allswell | Pre-Seed | $1.3M | — |
 JUNIPER GENOMICS | Seed | $4.6M | — |
 Testmate | Seed | $6M | — |
Top Co-Investors
RH Capital3 shared
Echo2 shared
Flybridge Capital Partners2 shared
Larsen Ventures2 shared
Ingeborg Investments2 shared
The Helm2 shared
Harlem Capital1 shared
CityRock Venture Partners1 shared
Precursor Ventures1 shared
JLL Spark1 shared
8VC1 shared
The Blue Venture Fund1 shared
Alumni Ventures1 shared
Health2047 Capital Partners1 shared
JAZZ Venture Partners1 shared
Labcorp1 shared
Left Lane Capital1 shared
Virtue1 shared
G9 Ventures1 shared
General Catalyst1 shared
Last updated: 8 September 2026